EnteroMedics completes follow-on

On Jan. 18, metabolic medical device company EnteroMedics Inc. (NASDAQ:ETRM) raised $16.5 million through the sale of 751,412 class A units at $5.31 and 12,531 class B units at $1,000 in a follow-on u...